Trademark Overview
On Wednesday, February 26, 2025, a trademark application was filed for SYNCRETIN with the United States Patent and Trademark Office. The USPTO has given the SYNCRETIN trademark a serial number of 99057963. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, February 26, 2025. This trademark is owned by Abiologics, Inc.. The SYNCRETIN trademark is filed in the Chemical Products and Treatment & Processing of Materials Services categories with the following description:
Custom manufacturing of genetically engineered proteins and peptides; custom manufacturing of engineered proteins and peptides; custom manufacturing and custom synthesis of engineered proteins and peptides for scientific, engineering, research, and medical use; custom manufacturing of synthetic proteins and peptides
Proteins for use in manufacture; synthetic proteins and synthetic peptides, in raw material form, for scientific and medical research; synthetic proteins and synthetic peptides for medical diagnostic purposes; synthetic proteins and synthetic peptides for use in connection with appetite control, body weight management, metabolism, cardiovascular and renal diseases, neurological and neurodegenerative diseases, brain health, substance use disorder, pain, neuropsychiatry, inflammation, and immunology; biomedical compounds, namely, peptide substrates used in analyzing and detecting toxins
